Most Recent Publications Search A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer 07-2025 T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains 06-2025 T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine 05-2025 POSTER: Enhancing Immunogenicity Risk Assessment: Leveraging ISPRI for Bispecific Antibody Analysis 04-2025 Regulatory T cell epitope content in human antibodies decreases during maturation 04-2025 Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches 03-2025 Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods 08-2024 Poster: Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods 05-2024 Poster: Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods 05-2024 Poster: Comprehensive assessment of immunogenicity risk of host cell proteins in biologics and vaccines using in silico and in vitro methods 05-2024 Poster: An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics) 05-2024 Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis 05-2024 « Older Entries
A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer 07-2025
T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains 06-2025
T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine 05-2025
POSTER: Enhancing Immunogenicity Risk Assessment: Leveraging ISPRI for Bispecific Antibody Analysis 04-2025
Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods 08-2024
Poster: Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods 05-2024
Poster: Comprehensive assessment of immunogenicity risk of host cell proteins in biologics and vaccines using in silico and in vitro methods 05-2024
Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis 05-2024
